EP1200133A4 - Manipulation des gewebe- oder organtyps mittels notch-signalweg - Google Patents
Manipulation des gewebe- oder organtyps mittels notch-signalwegInfo
- Publication number
- EP1200133A4 EP1200133A4 EP99933914A EP99933914A EP1200133A4 EP 1200133 A4 EP1200133 A4 EP 1200133A4 EP 99933914 A EP99933914 A EP 99933914A EP 99933914 A EP99933914 A EP 99933914A EP 1200133 A4 EP1200133 A4 EP 1200133A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- manipulation
- tissue
- notch pathway
- organ type
- organ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/42—Notch; Delta; Jagged; Serrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07002048A EP1772514A3 (de) | 1999-07-12 | 1999-07-12 | Manipulation des Gewebe- oder Organtyps Mittels Notch-Signal Weg |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1999/015727 WO2001003743A1 (en) | 1999-07-12 | 1999-07-12 | Manipulation of tissue or organ type using the notch pathway |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07002048A Division EP1772514A3 (de) | 1999-07-12 | 1999-07-12 | Manipulation des Gewebe- oder Organtyps Mittels Notch-Signal Weg |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1200133A1 EP1200133A1 (de) | 2002-05-02 |
EP1200133A4 true EP1200133A4 (de) | 2003-05-28 |
Family
ID=22273183
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07002048A Withdrawn EP1772514A3 (de) | 1999-07-12 | 1999-07-12 | Manipulation des Gewebe- oder Organtyps Mittels Notch-Signal Weg |
EP99933914A Ceased EP1200133A4 (de) | 1999-07-12 | 1999-07-12 | Manipulation des gewebe- oder organtyps mittels notch-signalweg |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07002048A Withdrawn EP1772514A3 (de) | 1999-07-12 | 1999-07-12 | Manipulation des Gewebe- oder Organtyps Mittels Notch-Signal Weg |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1772514A3 (de) |
JP (1) | JP4652645B2 (de) |
AU (1) | AU774188B2 (de) |
CA (1) | CA2378465A1 (de) |
WO (1) | WO2001003743A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002308557A1 (en) | 2001-05-01 | 2002-11-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
GB0118223D0 (en) * | 2001-07-26 | 2001-09-19 | Univ Sheffield | Stem loop RNA |
GB0123379D0 (en) * | 2001-09-28 | 2001-11-21 | Lorantis Ltd | Modulators |
JP2004290193A (ja) * | 2003-03-12 | 2004-10-21 | Ishihara Sangyo Kaisha Ltd | 細胞増殖、発生分化が改変された植物細胞及び植物体 |
US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
TW201210584A (en) | 2010-08-18 | 2012-03-16 | Alcon Res Ltd | Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma |
JP6105838B2 (ja) * | 2010-08-24 | 2017-03-29 | 国立大学法人 岡山大学 | 疼痛の治療剤 |
MY188836A (en) | 2013-11-22 | 2022-01-07 | Sumitomo Chemical Co | Method for manufacturing telencephalon or progenitor tissue thereof |
JP6304818B2 (ja) * | 2014-04-21 | 2018-04-04 | 花王株式会社 | 皮膚由来多能性前駆細胞の作製方法 |
EP3868393A4 (de) * | 2018-10-19 | 2022-06-08 | ICM Co., Ltd. | Pharmazeutische zusammensetzung zur behandlung von retinaerkrankungen mit nkx3.2 und einem fragment davon als wirkstoffe |
CN112445496A (zh) * | 2019-08-30 | 2021-03-05 | 北汽福田汽车股份有限公司 | 车辆电控单元的刷写方法和系统,移动终端及车载交互终端 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780300A (en) * | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
WO1998048829A1 (en) * | 1997-05-01 | 1998-11-05 | The Rockefeller University | A vertebrate lens obtained from an ectodermal cell and methods of use thereof |
-
1999
- 1999-07-12 AU AU49864/99A patent/AU774188B2/en not_active Ceased
- 1999-07-12 EP EP07002048A patent/EP1772514A3/de not_active Withdrawn
- 1999-07-12 WO PCT/US1999/015727 patent/WO2001003743A1/en active IP Right Grant
- 1999-07-12 EP EP99933914A patent/EP1200133A4/de not_active Ceased
- 1999-07-12 JP JP2001509216A patent/JP4652645B2/ja not_active Expired - Lifetime
- 1999-07-12 CA CA002378465A patent/CA2378465A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780300A (en) * | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
WO1998048829A1 (en) * | 1997-05-01 | 1998-11-05 | The Rockefeller University | A vertebrate lens obtained from an ectodermal cell and methods of use thereof |
Non-Patent Citations (2)
Title |
---|
FORTINI MARK E ET AL: "An activated notch receptor blocks cell-fate commitment in the developing Drosophila eye.", NATURE (LONDON), vol. 365, no. 6446, 1993, pages 555 - 557, XP001056504, ISSN: 0028-0836 * |
See also references of WO0103743A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP4652645B2 (ja) | 2011-03-16 |
CA2378465A1 (en) | 2001-01-18 |
AU774188B2 (en) | 2004-06-17 |
EP1200133A1 (de) | 2002-05-02 |
EP1772514A2 (de) | 2007-04-11 |
JP2003530820A (ja) | 2003-10-21 |
AU4986499A (en) | 2001-01-30 |
EP1772514A3 (de) | 2007-06-20 |
WO2001003743A1 (en) | 2001-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2353220B (en) | Surgical instrument | |
AU7205601A (en) | Organ tissue manipulator | |
DE69914343D1 (de) | Medizinisches implantat | |
ZA981426B (en) | Endoscopic surgical instrument | |
IL155071A0 (en) | Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same | |
AU2001232360A1 (en) | Medical instrument | |
GB9915414D0 (en) | Medical use | |
IL152353A0 (en) | Medical implant | |
GB0011244D0 (en) | Tissue regrafting | |
IL148051A0 (en) | Finger-guided surgical instrument | |
FR2794019B1 (fr) | Implant d'osteosynthese | |
AU142196S (en) | Tissue | |
EP1200133A4 (de) | Manipulation des gewebe- oder organtyps mittels notch-signalweg | |
GB9802599D0 (en) | Medical use | |
AU4117400A (en) | Medical instruments | |
AU4841499A (en) | Human transferases | |
AU2001264631A1 (en) | Medical instrument | |
GB2353477B (en) | Medical endoscope | |
GB9907965D0 (en) | Medical use | |
GB0001443D0 (en) | Medical endoscope | |
GB9910377D0 (en) | Tissue engineering | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
AU142195S (en) | Tissue | |
GB9925379D0 (en) | Medical use | |
AU140956S (en) | Tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020211 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030411 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07K 14/47 B Ipc: 7A 61P 35/00 B Ipc: 7A 61K 38/17 B Ipc: 7C 12N 5/06 A |
|
17Q | First examination report despatched |
Effective date: 20030923 |
|
APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
APAZ | Date of receipt of statement of grounds of appeal deleted |
Free format text: ORIGINAL CODE: EPIDOSDNOA3E |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20080605 |